by Ted Purlain on June 1, 2010
Gardasil is already recommended to be administered to girls ages 11 to 12 as a routine vaccine, according to the report. The CDC’s Advisory Committee for Immunization Practices did not go so far as to recommend routine vaccination for men as it is not a cost effective way to prevent the spread of human papillomavirus infection, Time reports.
The report calls the CDC’s recommendation vague on how exactly men should use the shot and who would most benefit from receiving one.
Time reports that the recommendation states that Gardasil “would be most effective when given exposure to HPV through sexual contact.”
The CDC says more specific details will be coming involving higher risk populations, because the U.S. Food and Drug Administration is still reviewing data about the vaccine’s effectiveness in preventing pre-cancerous growths among homosexual and bisexual men.
The CDC’s recommendation is specific to Gardasil and does not apply to Cervarix, the HPV vaccine that was approved in 2009 by the FDA. That vaccine targets only HPV’s cancer-causing strains and not the strains that are primarily responsible for genital warts.